These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 18843572)
1. The role of structural and functional imaging in parkinsonian states with a description of PET technology. Brooks DJ Semin Neurol; 2008 Sep; 28(4):435-45. PubMed ID: 18843572 [TBL] [Abstract][Full Text] [Related]
5. Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts. Saeed U; Compagnone J; Aviv RI; Strafella AP; Black SE; Lang AE; Masellis M Transl Neurodegener; 2017; 6():8. PubMed ID: 28360997 [TBL] [Abstract][Full Text] [Related]
6. Functional imaging studies of non-motoric manifestations of Parkinson's Disease. Stoessl AJ Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S13-6. PubMed ID: 20082973 [TBL] [Abstract][Full Text] [Related]
7. PET studies of the striatal dopaminergic system in Parkinson's disease (PD). Piccini P; Turjanski N; Brooks DJ J Neural Transm Suppl; 1995; 45():123-31. PubMed ID: 8748617 [TBL] [Abstract][Full Text] [Related]
8. Neuroimaging in Parkinson's disease. Au WL; Adams JR; Troiano A; Stoessl AJ J Neural Transm Suppl; 2006; (70):241-8. PubMed ID: 17017536 [TBL] [Abstract][Full Text] [Related]
9. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease]. Arahata Y; Kato T; Tadokoro M; Sobue G Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454 [TBL] [Abstract][Full Text] [Related]
10. Clinical, Dopaminergic, and Metabolic Correlations in Parkinson Disease: A Dual-Tracer PET Study. Liu FT; Ge JJ; Wu JJ; Wu P; Ma Y; Zuo CT; Wang J Clin Nucl Med; 2018 Aug; 43(8):562-571. PubMed ID: 29863572 [TBL] [Abstract][Full Text] [Related]
11. Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging. Eckert T; Feigin A; Lewis DE; Dhawan V; Frucht S; Eidelberg D Mov Disord; 2007 Jan; 22(2):167-73. PubMed ID: 17133454 [TBL] [Abstract][Full Text] [Related]
12. Imaging in Parkinson's Disease. Politis M; Pagano G; Niccolini F Int Rev Neurobiol; 2017; 132():233-274. PubMed ID: 28554409 [TBL] [Abstract][Full Text] [Related]
13. SPECT imaging of the dopaminergic system in (premotor) Parkinson's disease. Booij J; Knol RJ Parkinsonism Relat Disord; 2007; 13 Suppl 3():S425-8. PubMed ID: 18267276 [TBL] [Abstract][Full Text] [Related]
15. Perfusion and metabolism imaging studies in Parkinson's disease. Borghammer P Dan Med J; 2012 Jun; 59(6):B4466. PubMed ID: 22677251 [TBL] [Abstract][Full Text] [Related]
16. Comparison of cerebral glucose metabolism between multiple system atrophy Parkinsonian type and Parkinson's disease. Feng T; Wang Y; Ouyang Q; Duan Z; Li W; Lu L; Xiang W Neurol Res; 2008 May; 30(4):377-82. PubMed ID: 18544255 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease. Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ Eur J Neurol; 2008 Oct; 15(10):1043-9. PubMed ID: 18717730 [TBL] [Abstract][Full Text] [Related]
18. PET and SPECT functional imaging studies in Parkinsonian syndromes: from the lesion to its consequences. Thobois S; Jahanshahi M; Pinto S; Frackowiak R; Limousin-Dowsey P Neuroimage; 2004 Sep; 23(1):1-16. PubMed ID: 15325346 [TBL] [Abstract][Full Text] [Related]
19. PET studies on the early and differential diagnosis of Parkinson's disease. Brooks DJ Neurology; 1993 Dec; 43(12 Suppl 6):S6-16. PubMed ID: 8264913 [TBL] [Abstract][Full Text] [Related]
20. New developments of brain imaging for Parkinson's disease and related disorders. Piccini P; Brooks DJ Mov Disord; 2006 Dec; 21(12):2035-41. PubMed ID: 16874751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]